# The Role of Lipid Transporter MFSD2A in the Resolution of Colorectal Cancer-associated Inflammation

> **NCT06071598** · — · UNKNOWN · sponsor: **IRCCS San Raffaele** · enrollment: 15 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **OTHER:** Surgical specimens of CRC-affected patients

## Key facts

- **NCT ID:** NCT06071598
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-15
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-03-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06071598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06071598, "The Role of Lipid Transporter MFSD2A in the Resolution of Colorectal Cancer-associated Inflammation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06071598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*